Related Experiment Video
Updated: Mar 6, 2026
Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
Published on: January 17, 2020
Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders
Bradley C Nelson1, Sherin I Hashem1, Eric D Adler2
1Department of Medicine, Division of Cardiology, University of California San Diego, 9500 Gilman Drive, Biomedical Research Facility, Room 1217 AA, La Jolla, CA, 92093, USA.
Insights
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) effectively model cardiac storage disorders like Anderson-Fabry disease. These hiPSC-CMs offer valuable insights for future research and targeted therapies.
Area of Science:
- Biomedical research
- Cardiology
- Stem cell technology
Background:
- Cardiac storage disorders (CSDs) are a group of genetic conditions affecting the heart.
- Patient-specific human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are increasingly used to model genetic diseases.
- Understanding CSDs is crucial for developing effective treatments.
Purpose of the Study:
- To review existing hiPSC-CM models for cardiac storage disorders.
- To evaluate the strengths and weaknesses of these hiPSC-CM models.
- To explore future applications of hiPSC-CM technology in CSD research.
Main Methods:
- Literature review of published studies on hiPSC-CM models of CSDs.
- Analysis of phenotypic features recapitulated by hiPSC-CMs.
- Assessment of hiPSC-CM response to pharmacologic interventions.
Main Results:
- hiPSC-CMs have been successfully developed for Anderson-Fabry disease, Danon disease, and Pompe disease.
- These models accurately reflect key disease characteristics and respond to drug treatments.
- hiPSC-CMs serve as a reliable in vitro system for studying human cardiomyocytes in the context of CSDs.
Conclusions:
- hiPSC-CMs are valuable tools for modeling cardiac storage disorders.
- Despite limitations, these models show significant promise for future mechanistic studies.
- hiPSC-CMs are expected to aid in the development of targeted therapeutics for CSDs.
Purpose Of Review:
The aim of this study is to review the published human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) models of cardiac storage disorders and to evaluate the limitations and future applications of this technology.
Recent Findings:
Several cardiac storage disorders (CSDs) have been modeled using patient-specific hiPSC-CMs, including Anderson-Fabry disease, Danon disease, and Pompe disease. These models have shown that patient-specific hiPSC-CMs faithfully recapitulate key phenotypic features of CSDs and respond predictably to pharmacologic manipulation. hiPSC-CMs generated from patients with CSDs are representative models of the patient disease state and can be used as an in vitro system for the study of human cardiomyocytes. While these models suffer from several limitations, they are likely to play an important role in future mechanistic studies of cardiac storage disorders and the development of targeted therapeutics for these diseases.
More Related Videos
08:37Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
Published on: March 3, 2021
09:23Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
Published on: March 10, 2023
